XML 61 R38.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Plans (Details) (USD $)
3 Months Ended 9 Months Ended
Nov. 01, 2014
Aug. 02, 2014
May 03, 2014
Nov. 02, 2013
Nov. 01, 2014
Nov. 02, 2013
Feb. 01, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Allocated Share-based Compensation Expense $ 3,000,000     $ 3,700,000 $ 8,000,000 $ 11,500,000  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]              
Weighted-average fair value of stock options granted       $ 11.83   $ 12.08  
Risk-free interest rate       1.10%   0.70%  
Expected life (years)       4 years 2 months 12 days   4 years 2 months 12 days  
Expected volatility       39.90%   42.10%  
Expected annual forfeiture rate       3.00%   3.00%  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]              
Outstanding stock options 2,479,135 2,994,235 3,377,303   3,377,303    
Granted         0    
Exercised (541,797) (464,400) (243,218)        
Forfeited (72,500) (50,700) (139,850)        
Outstanding stock options 1,864,838 2,479,135 2,994,235   1,864,838    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]              
Options, Vested and Expected to Vest, Outstanding, Number 1,775,684       1,775,684    
Options, Exercisable, Number 895,774       895,774    
Options, Outstanding, Weighted Average Exercise Price $ 37.52 $ 35.00 $ 35.35   $ 37.52   $ 34.88
Options, Exercises in Period, Weighted Average Exercise Price $ 25.75 $ 36.73 $ 26.90        
Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $ 39.15 $ 40.35 $ 38.63        
Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price $ 37.48       $ 37.48    
Options, Exercisable, Weighted Average Exercise Price $ 36.89       $ 36.89    
Options, Outstanding, Weighted Average Remaining Contractual Term 4 years 3 months 18 days 4 years 1 month 4 years 2 months 18 days        
Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term 4 years 2 months 12 days            
Options, Exercisable, Weighted Average Remaining Contractual Term 3 years 6 months            
Options, Outstanding, Intrinsic Value 15,162,000 20,850,000 16,314,000   15,162,000    
Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 14,515,000       14,515,000    
Options, Exercisable, Intrinsic Value 7,845,000       7,845,000    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]              
Total intrinsic value of stock options exercised 11,050,000     625,000 16,980,000 2,414,000  
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized 23,800,000       23,800,000    
Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition 2 years 0 months 2 days            
Stock Options [Member]
             
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]              
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period         4 years    
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date         7 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]              
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period         4 years    
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date         7 years    
Restricted Stock [Member]
             
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]              
Nonvested, beginning balance 819,178 832,457 664,101   664,101    
Granted 2,012 32,987 281,056        
Vested (31,000) (23,776) (13,500)        
Forfeited (28,990) (22,490) (99,200)        
Nonvested, ending balance 761,200 819,178 832,457   761,200    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]              
Nonvested, Weighted Average Grant Date Fair Value $ 38.16 $ 38.04 $ 37.77   $ 38.16   $ 38.34
Grants in Period, Weighted Average Grant Date Fair Value $ 43.87 $ 42.86 $ 37.12        
Vested in Period, Weighted Average Grant Date Fair Value $ 34.75 $ 33.65 $ 34.75        
Forfeited in Period, Weighted Average Grant Date Fair Value $ 38.84 $ 39.61 $ 40.19        
Restricted Stock [Member] | Nonemployee Board of Directors [Member]
             
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]              
Vested   (23,776)          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]              
Deferred Compensation Arrangement, Fair Value of Shares Issued to Each Director   110,000          
Restricted Stock Awards (RSAs) [Member]
             
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]              
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period         5 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]              
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period         5 years    
Total fair value of equity instrument other than options vested 1,325,000     0 2,736,000 1,434,000  
Restricted Stock Awards (RSAs) [Member] | Current [Member]
             
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]              
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period         5 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]              
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period         5 years    
Restricted Stock Units (RSUs) [Member]
             
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]              
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period         3 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]              
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period         3 years    
Performance Shares [Member]
             
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]              
Allocated Share-based Compensation Expense         0    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]              
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period         3 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]              
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period         434,124    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period         3 years    
CEO Performance Share Units [Member]
             
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]              
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date         7 years    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]              
Nonvested, beginning balance     37,800   37,800    
Vested (12,600) (12,600)          
Nonvested, ending balance 12,600       12,600    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]              
Nonvested, Weighted Average Grant Date Fair Value             $ 34.68
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date         7 years    
Total fair value of equity instrument other than options vested $ 585,000     $ 0 $ 1,143,000 $ 0